Skip to Content
MDPIMDPI
Current OncologyCurrent Oncology
PDF
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
  • Article
  • Open Access

1 August 2008

Defining the Optimal Treatment Strategy for Localized Prostate Cancer Patients: A Survey of Ongoing Studies at the National Cancer Institute of Canada Clinical Trials Group

,
,
,
,
,
,
,
,
and
1
National Cancer Institute of Canada Clinical Trials Group, Kingston, ON, Canada
2
BC Cancer Agency, Vancouver, BC, Canada
3
Sunnybrook Health Sciences Centre, Toronto, ON, Canada
4
Princess Margaret Hospital, Toronto, ON, Canada
Curr. Oncol.2008, 15(4), 179-184;https://doi.org/10.3747/co.v15i4.257
Version Notes
Order Reprints

Abstract

The designation “clinically localized prostate cancer” comprises a group of biologically heterogeneous tumours with different growth rates and risks of relapse. Because prostate cancer is primarily a disease of older men, treatment selection must take into account the prognosis of the tumour, patient age, comorbidities, side effects of treatment, and patient preferences. Clinical trials must identify the various prognostic groups and test the appropriate treatment strategies within these subgroups.

Article Metrics

Citations

Article Access Statistics

Journal Statistics
Multiple requests from the same IP address are counted as one view.
The Economic Impact on Families When a Child Is Diagnosed with Cancer
Previous
Healing and Survivorship: What Makes a Difference?
Next